Cheryl's Experience with Long COVID and Managing Symptoms

Today, Cheryl from Australia, shares her story of LDN for long Covid that resulted in fibromyalgia and chronic fatigue syndrome.

Jade's Journey: Overcoming Health Challenges with LDN

Pharmacy Times
June 25, 2025
Having a Healthy Gut, Diet Are Key Factors for Long COVID Management
Author: Luke Halpern, Assistant Editor

ORIGINAL RESEARCH article

Front. Mol. Biosci., 19 May 2025

Sec. Molecular Diagnostics and Therapeutics

Volume 12 - 2025 | https://doi.org/10.3389/fmolb.2025.1582967

Low-Dose naltrexone restored TRPM3 ion channel function in natural killer cells from long COVID patients

Etianne Martini Sasso, Natalie Eaton-Fitch, Peter Smith, Katsuhiko Muraki & Sonya Marshell-Gradisnik

Opioid Addiction Drug Restores Function in Cells From Long COVID Patients
The study provides hope for the millions suffering from long COVID.

Published: May 20, 2025 | Original story from Griffith University

https://www.technologynetworks.com/tn/news/opioid-addiction-drug-restores-function-in-cells-from-long-covid-patients-399895

ORIGINAL RESEARCH article

Frontiers in Molecular Biosciences

Sec. Molecular Diagnostics and Therapeutics

Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1582967

Low-Dose Naltrexone restored TRPM3 ion channel function in Natural Killer cells from long COVID patients

Etianne Martini Sasso et al.

8th April 2025

Trump And RFK Should Accelerate Inexpensive Treatments For Long Covid And Other Diseases

The Federalist, Pierre Kory
March 25, 2025

https://thefederalist.com/2025/03/25/how-rfk-can-accelerate-inexpensive-treatments-for-long-covid/

Generic drugs can combat an array of chronic diseases, but only if the Trump administration creates a structured, interdisciplinary study of these drugs.

Protocol for Vaccine Injury Management
Based on the immune picture revealed by Yale LISTEN study

Koolbeens cafe, March 02, 2025

Low-dose naltrexone shows promise for long COVID

New Zealand Doctor Rata Aotearoa

David Codyre

Wednesday 8 January 2025

Psychiatrist David Codyre reviews the growing evidence for low-dose naltrexone in the treatment of functional syndromes such as fibromyalgia, chronic fatigue and long COVID

Key points, In low doses (typically 3–4.5mg daily), naltrexone appears to modulate  ... 

Subscription required: Follow link i f you have, or want, a subscription to this medical website

Beyond Antivirals: Alternative Therapies for Long COVID

Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou

19 November 2024

Viruses